 |
인쇄하기
취소
|
Ultrasound contrast agent Sonazoid for Injection released for sale
GE Healthcare Korea said today that it has rolled out the ultrasound contrast agent Sonazoid for Injection, which has been marketed in Japan since 2007.
Sonazoid for injection was developed jointly by Daiichi Pharmaceutical and GE Healthcare, the healthcare unit of General Electric Company.
A minimally invasive contrast agent, Sonazoid for Injection is characterized by a prolonged abilit...
Sonazoid for injection was developed jointly by Daiichi Pharmaceutical and GE Healthcare, the healthcare unit of General Electric Company.
A minimally invasive contrast agent, Sonazoid for Injection is characterized by a prolonged abilit...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.